Von dem Buch Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop Summary haben wir 3 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Board on Health Care Services: Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop Summary (ISBN: 9780309161572) 2010, National Academies Press, in Englisch, auch als eBook.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
100%: Board on Health Care Services: Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop Summary (ISBN: 9780309156554) 2010, National Academies Press, in Englisch, auch als eBook.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
91%: Institute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Editor: Erin Balogh, Editor: Sharyl J. Nass, Editor: Margie Patlak: Extending the Spectrum Precompetitive Collaboration in Oncology Research: Workshop Summary (ISBN: 9780309156547) 2010, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop Summary
7 Angebote vergleichen
Bester Preis: € 42,86 (vom 07.09.2019)1
Symbolbild
na
Extending the Spectrum of Precompetitive Collaboration (2010)
EN PB NWISBN: 9780309156547 bzw. 0309156548, in Englisch, National Academy of Sciences, Vereinigte Staaten von Amerika, Taschenbuch, neu.
Lieferung aus: Indien, Versandkosten nach: USA.
Von Händler/Antiquariat, OVERSEAS BOOKSTORE.
2010. Paperback . New. Brand New, Never Used, IN-STOCK, Well Packed. Orders ship the same or next business day. Shipping should take from 3-4 business days within US, Canada, UK, and other EU countries, 2-3 business days within Australia, Japan, and Singapore. Customer satisfaction guaranteed. Mail us if you have any questions.
Von Händler/Antiquariat, OVERSEAS BOOKSTORE.
2010. Paperback . New. Brand New, Never Used, IN-STOCK, Well Packed. Orders ship the same or next business day. Shipping should take from 3-4 business days within US, Canada, UK, and other EU countries, 2-3 business days within Australia, Japan, and Singapore. Customer satisfaction guaranteed. Mail us if you have any questions.
2
Extending the Spectrum of Precompetitive Collaboration in Oncology Research, Workshop Summary (2010)
EN PB NWISBN: 9780309156547 bzw. 0309156548, in Englisch, National Academies Press, Taschenbuch, neu.
Lieferung aus: Niederlande, Vermoedelijk 4-6 weken.
bol.com.
Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative ... Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative approaches to drug development, if we are to continue to improve clinical care and reduce mortality. These challenges create opportunities for improved collaboration between industry, academia, government, and philanthropic organizations at each stage in new drug development, marketing, and implementation. Perhaps the most appropriate initial step in addressing the need for collaboration is to consider more precompetitive relationships that allow sharing of scientific information to foster drug development. While these collaborative relationships in basic and preclinical research on drug targets and the early stages of clinical testing are acknowledged to be potentially important drivers for innovation and more rapid marketing of new agents, they also raise a number of concerns that must be addressed. For example, acknowledgment of academic productivity and independence and economic competitiveness must be considered and these challenges managed to foster a culture of collaboration. At the same time, regulatory issues, the need for standardization, and intellectual property concerns must be confronted if the current models for drug development are to be refined to encourage robust participation in precompetitive collaborations. Recognizing the growing importance of precompetitive collaborations in oncology drug development, as well as the challenges these innovative collaborations pose, the National Cancer Policy Forum of the Institute of Medicine held a workshop on February 9 and 10, 2010. This book is a summary of the workshop proceedings.Taal: Engels;Afmetingen: 0x229x152 mm;Gewicht: 181,00 gram;Verschijningsdatum: september 2010;ISBN10: 0309156548;ISBN13: 9780309156547; Engelstalig | Paperback | 2010.
bol.com.
Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative ... Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative approaches to drug development, if we are to continue to improve clinical care and reduce mortality. These challenges create opportunities for improved collaboration between industry, academia, government, and philanthropic organizations at each stage in new drug development, marketing, and implementation. Perhaps the most appropriate initial step in addressing the need for collaboration is to consider more precompetitive relationships that allow sharing of scientific information to foster drug development. While these collaborative relationships in basic and preclinical research on drug targets and the early stages of clinical testing are acknowledged to be potentially important drivers for innovation and more rapid marketing of new agents, they also raise a number of concerns that must be addressed. For example, acknowledgment of academic productivity and independence and economic competitiveness must be considered and these challenges managed to foster a culture of collaboration. At the same time, regulatory issues, the need for standardization, and intellectual property concerns must be confronted if the current models for drug development are to be refined to encourage robust participation in precompetitive collaborations. Recognizing the growing importance of precompetitive collaborations in oncology drug development, as well as the challenges these innovative collaborations pose, the National Cancer Policy Forum of the Institute of Medicine held a workshop on February 9 and 10, 2010. This book is a summary of the workshop proceedings.Taal: Engels;Afmetingen: 0x229x152 mm;Gewicht: 181,00 gram;Verschijningsdatum: september 2010;ISBN10: 0309156548;ISBN13: 9780309156547; Engelstalig | Paperback | 2010.
3
Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop Summary (2010)
~EN NW EB DLISBN: 9780309161572 bzw. 0309161576, vermutlich in Englisch, National Academies Press, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Free shipping.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
4
Extending the Spectrum of Precompetitive Collaboration in Oncology Research - Workshop Summary (2010)
~EN NW EB DLISBN: 9780309156554 bzw. 0309156556, vermutlich in Englisch, National Academies Press, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Free shipping.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
5
Symbolbild
Extending the Spectrum Precompetitive Collaboration in Oncology Research: Workshop Summary (2010)
EN PB USISBN: 9780309156547 bzw. 0309156548, in Englisch, National Academies Press, Taschenbuch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, Books From California, CA, Simi Valley, [RE:4].
As New Condition-Over 500, 000 Internet Orders Shipped. Paperback.
Von Händler/Antiquariat, Books From California, CA, Simi Valley, [RE:4].
As New Condition-Over 500, 000 Internet Orders Shipped. Paperback.
6
Symbolbild
Extending the Spectrum Precompetitive Collaboration in Oncology Research: Workshop Summary (2010)
EN PB USISBN: 9780309156547 bzw. 0309156548, in Englisch, National Academies Press, Taschenbuch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, Better World Books, IN, Mishawaka, [RE:4].
Paperback.
Von Händler/Antiquariat, Better World Books, IN, Mishawaka, [RE:4].
Paperback.
7
Symbolbild
Extending the Spectrum Precompetitive Collaboration in Oncology Research: Workshop Summary (2010)
EN PB USISBN: 9780309156547 bzw. 0309156548, in Englisch, National Academies Press, Taschenbuch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, Better World Books West, IN, Mishawaka, [RE:4].
Paperback.
Von Händler/Antiquariat, Better World Books West, IN, Mishawaka, [RE:4].
Paperback.
Lade…